Eyes on the BA2 strain
Vermont Health Commissioner Dr. Mark Levine at Tuesday's press briefing
MONTPELIER- Even as COVID-19 infections and hospitalizations continue to fall in Vermont, the state is evaluating the potential impact of BA2, a variant of the COVID-19 Omicron strain.
“We continue to monitor any developments concerning the BA2 subvariant of Omicron, both abroad and here in Vermont, through genetic sequencing and waste water surveillance,” said Vermont Health Commissioner Dr. Mark Levine at Tuesday’s COVID-19 press briefing. “Unfortunately, we cannot predict exactly how it will affect us yet.”
Support local journalism. Access to our full website, including e-edition archives, starts at only $2.
Click here to learn more about subscription options.
Are you a current online subscriber? Click to login.
If you have a print subscription, you can now add online access at no additional charge. Just email us with your name and mailing address to set it up.
Thank you for supporting community journalism and The Deerfield Valley News.
